Literature DB >> 7625193

Cotard's syndrome: analysis of 100 cases.

G E Berrios1, R Luque.   

Abstract

In 1880, Jules Cotard reported a clinical state he believed was a new type of agitated melancholia. A statistical analysis has been carried out of 100 cases of Cotard's syndrome to determine how this clinical concept has fared since its inception. In terms of clinical profile, no difference was found between men and women or between underlying diagnostic categories; age seemed to increase the likelihood of developing délire des négations. Depression was reported in 89% of subjects; the most common nihilistic delusions concerned the body (86%) and existence (69%). Anxiety (65%) and guilt (63%) were also common, followed by hypochondriacal delusions (58%) and delusions of immortality (55). An exploratory factor analysis extracted 3 factors: psychotic depression, Cotard type I and Cotard type II. The psychotic depression factor included patients with melancholia and few nihilistic delusions. Cotard type 1 patients, on the other hand, showed no loadings for depression or other disease and are likely to constitute a pure Cotard syndrome whose nosology may be closer to the delusional than the affective disorders. Type II patients showed anxiety, depression and auditory hallucinations and constitute a mixed group. This new grouping cuts across the more traditional view and may have therapeutic implications. Authors, in general, have considered délire des négations as a syndrome rather than a new disease and do not seem to support the view that the completeness of the syndrome is a function of presence or severity of depression. The view that délire des négations refers only to the delusion of being dead has also carried little favour as its likely to waste information.

Entities:  

Mesh:

Year:  1995        PMID: 7625193     DOI: 10.1111/j.1600-0447.1995.tb09764.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  22 in total

1.  Death delusion.

Authors:  Anders Helldén; Ingegerd Odar-Cederlöf; Kajsa Larsson; Ingela Fehrman-Ekholm; Thomas Lindén
Journal:  BMJ       Date:  2007-12-22

Review 2.  Cotard's syndrome: a review.

Authors:  Hans Debruyne; Michael Portzky; Frédérique Van den Eynde; Kurt Audenaert
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

Review 3.  Incarnation and animation: physical versus representational deficits of body integrity.

Authors:  Leonie Maria Hilti; Peter Brugger
Journal:  Exp Brain Res       Date:  2009-10-25       Impact factor: 1.972

4.  Phenomenological and neurocognitive perspectives on polythematic and monothematic delusions.

Authors:  Max Coltheart
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

5.  The inside of me: interoceptive constraints on the concept of self in neuroscience and clinical psychology.

Authors:  Alessandro Monti; Giuseppina Porciello; Maria Serena Panasiti; Salvatore Maria Aglioti
Journal:  Psychol Res       Date:  2021-05-28

6.  Cotard Syndrome: "I'm Dead, So Why Do I Need to Eat?".

Authors:  Susan Solimine; Selena Chan; Sarah K Morihara
Journal:  Prim Care Companion CNS Disord       Date:  2016-03-17

7.  Cotard syndrome in semantic dementia.

Authors:  Mario F Mendez; Jesús Ramírez-Bermúdez
Journal:  Psychosomatics       Date:  2011 Nov-Dec       Impact factor: 2.386

Review 8.  Late Onset First Episode Psychosis Emerging as Delusional Misidentification of Familiar Sacred Places During a Holy Pilgrimage: A Case Report and Literature Review.

Authors:  Mahmoud A Awara; Hamdy F Moselhy; Manal O Elnenaei
Journal:  J Relig Health       Date:  2018-12

9.  Capgras' syndrome in first-episode psychotic disorders.

Authors:  Paola Salvatore; Chaya Bhuvaneswar; Mauricio Tohen; Hari-Mandir K Khalsa; Carlo Maggini; Ross J Baldessarini
Journal:  Psychopathology       Date:  2014-02-07       Impact factor: 1.944

10.  Cotard's syndrome with schizophreniform disorder can be successfully treated with electroconvulsive therapy: case report.

Authors:  Okan Caliyurt; Erdal Vardar; Cengiz Tuglu
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.